We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure [email protected]
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Driven by technological advances, an ever-increasing number of genes and mutations are implicated in neuromuscular diseases. This has led to revised classifications of neuromuscular diseases and expanding phenotypic spectra related to single genes. As a result, gene-targeted therapies are emerging. Combined with the reduction in costs of genome sequencing, genetic testing plays an increasingly important role in the diagnostic process of neuromuscular diseases. Nevertheless, caution is warranted since results of genome sequencing can be challenging regarding the interpretation of the results. Here we discuss general principles that aid the efficient use of genetic testing that may improve the interpretation of results (see Table 7.1).
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.